Overview

Clinical Study of in Situ Regeneration of Endometrium

Status:
Enrolling by invitation
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Thin endometrium will lead to hypomenorrhea,infertility and recurrent pregnancy loss and there are few effective methods to increase the endometrial thickness and improve the fertility outcomes. Patients with thin endometrium will be divided into three groups and receive estrogen therapy, stem cell therapy and growth factor therapy respectively. This randomized controlled clinical study is carried out to explore the optimal treatment method and best indications for thin endometrium.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Yali Hu
Collaborator:
Chinese Academy of Sciences
Treatments:
Estrogens